Beam Therapeutics Inc. Capital Expenditures Incurred but Not yet Paid
Beam Therapeutics Inc. (BEAM) reported Capital Expenditures Incurred but Not yet Paid of $814.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-04
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$577.00K.
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.39M, a 4.40% decline year-over-year.
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$1.85M, a 584.33% decline year-over-year.
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $2.15M.
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $1.27M, a 52.40% increase from fiscal 2024.
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $834.00K, a 40.56% decline from fiscal 2023.
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $1.40M, a 75.74% decline from fiscal 2022.
- Beam Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $5.78M, a 37.58% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$577.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $814.00K 10-Q · filed 2026-08-04 | -$1.04M derived: sum of 3 quarters · filed 2026-08-04 | $1.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.39M 10-Q · filed 2026-05-07 | -$464.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.69M derived: sum of 3 quarters · filed 2026-05-07 | $1.21M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $299.00K derived: sum of 2 quarters · filed 2026-02-24 | -$184.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.27M 10-K · filed 2026-02-24 |
| 2025-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.67M derived: sum of 2 quarters · filed 2026-08-04 | $3.13M 10-Q · filed 2025-11-04 | $3.51M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$483.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $972.00K 10-Q · filed 2026-08-04 | $1.35M derived: sum of 3 quarters · filed 2026-08-04 | $1.28M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.46M 10-Q · filed 2026-05-07 | $1.84M derived: sum of 2 quarters · filed 2026-05-07 | $1.77M derived: sum of 3 quarters · filed 2026-05-07 | $1.93M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $313.00K derived: sum of 2 quarters · filed 2026-02-24 | $476.00K derived: sum of 3 quarters · filed 2026-02-24 | $834.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $93.00K derived: sum of 2 quarters · filed 2025-11-04 | $451.00K 10-Q · filed 2025-11-04 | -$338.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $521.00K 10-Q · filed 2025-08-05 | -$268.00K derived: sum of 3 quarters · filed 2026-02-24 | -$3.71M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $358.00K 10-Q · filed 2025-05-06 | -$431.00K derived: sum of 2 quarters · filed 2026-02-24 | -$3.87M derived: sum of 3 quarters · filed 2026-02-24 | -$8.91M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$789.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$4.23M derived: sum of 2 quarters · filed 2026-02-24 | -$9.27M derived: sum of 3 quarters · filed 2026-02-24 | $1.40M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$8.48M derived: sum of 2 quarters · filed 2024-11-05 | $2.19M 10-Q · filed 2024-11-05 | $2.32M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $5.63M 10-Q · filed 2024-08-06 | $5.76M derived: sum of 3 quarters · filed 2025-02-25 | $2.53M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $10.68M 10-Q · filed 2024-05-07 | $10.80M derived: sum of 2 quarters · filed 2025-02-25 | $7.58M derived: sum of 3 quarters · filed 2025-02-25 | $1.15M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$3.10M derived: sum of 2 quarters · filed 2025-02-25 | -$9.52M derived: sum of 3 quarters · filed 2025-02-25 | $5.78M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$9.65M derived: sum of 2 quarters · filed 2023-11-08 | $5.66M 10-Q · filed 2023-11-08 | $7.41M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$6.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.88M 10-Q · filed 2023-08-08 | $10.63M derived: sum of 3 quarters · filed 2024-02-27 | $13.72M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $15.31M 10-Q · filed 2023-05-10 | $17.05M derived: sum of 2 quarters · filed 2024-02-27 | $20.14M derived: sum of 3 quarters · filed 2024-02-27 | $17.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.83M derived: sum of 2 quarters · filed 2024-02-27 | $2.59M derived: sum of 3 quarters · filed 2024-02-27 | $9.26M 10-K · filed 2024-02-27 |
| 2021-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $844.00K derived: sum of 2 quarters · filed 2022-11-07 | $7.51M 10-Q · filed 2022-11-07 | $9.77M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.43M 10-Q · filed 2022-08-09 | $6.69M derived: sum of 3 quarters · filed 2023-02-28 | $8.75M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $6.67M 10-Q · filed 2022-05-09 | $8.93M derived: sum of 2 quarters · filed 2023-02-28 | $10.99M derived: sum of 3 quarters · filed 2023-02-28 | $10.71M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.32M derived: sum of 2 quarters · filed 2023-02-28 | $4.04M derived: sum of 3 quarters · filed 2023-02-28 | $5.07M 10-K · filed 2023-02-28 |
| 2020-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.78M derived: sum of 2 quarters · filed 2021-11-08 | $2.81M 10-Q · filed 2021-11-08 | $4.22M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $747.00K 10-Q · filed 2021-08-10 | $2.16M derived: sum of 3 quarters · filed 2022-02-28 | $2.33M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.03M 10-Q · filed 2021-05-11 | $2.45M derived: sum of 2 quarters · filed 2022-02-28 | $2.61M derived: sum of 3 quarters · filed 2022-02-28 | $1.92M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.58M derived: sum of 2 quarters · filed 2022-02-28 | $892.00K derived: sum of 3 quarters · filed 2022-02-28 | $2.46M 10-K · filed 2022-02-28 |
| 2019-09-30 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$524.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.05M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$689.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $884.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $1.57M 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |